
How Hong Kong's cafes reinvented themselves – from DJs and running clubs to vintage clothes
The first Social Club Series cafe party in Hong Kong. Photo: Handout
The subtext is louder than the bass: Hong Kong's cafe culture isn't just about flat whites and avocado toast any more. Coffee shops have morphed into the city's latest social experience – just look at these pop-up parties organised by the likes of Social Club Series. Why the change? According to the project's founders Isaac Woo and Sandy Lam, cafes have been adapting to Hong Kong's elevating rents and changing consumer behaviour.
Advertisement
'Post-pandemic,
Hong Kong's cafe culture has been in need of fresh fuel,' Lam says. 'There is a lot of competition and [fewer] people consuming, as the work-from-home culture has faded away and people spend their weekends in Shenzhen.'
The context is stark: Hong Kong's once-thriving F&B scene faces its worst downturn in decades. Tai Pan Bakery and
Bedu are among recent closures blamed on skyrocketing rents, shifting consumer habits and a growing weekend exodus to mainland China. Border crossings surged 48 per cent last year to 93 million in 2024, leaving local cafes and restaurants to compete for a shrinking pool of patrons.
'By organising pop-up concerts during non-peak hours, we're transforming cafes into alternative spaces of interest,' Woo says. 'We're creating moments worth showing up for and posting about. It's giving people new reasons to look at their neighbourhood coffee shops as must-visit weekend destinations.'
It's a win-win situation, according to the Social Club Series founders: cafes make money and attract a new pool of patrons, and customers get a fun afternoon out. 'Coffee shops offer a more inclusive, healthy environment,' Lam says. 'It's great for people [who are] not used to going clubbing, because they can dance their heart out and meet new people,' adds Woo.
Community anchors
Wazup Running Club at The Station in Hong Kong, which doubles as a community space for runners. Photo: Handout
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


South China Morning Post
38 minutes ago
- South China Morning Post
GSK signs US$12.5 billion licence deal with Hengrui as China rises in global pharmaceuticals
GlaxoSmithKline (GSK) will pay a Chinese company US$12.5 billion for exclusive global rights to develop a dozen drugs, in a landmark deal that underscores how China's research labs are snapping up market share in the global pharmaceutical and biomedical industries. The deal would give GSK the rights to develop a drug for treating chronic obstructive pulmonary disease (COPD) called HRS-9821, as well as 11 of the preclinical programmes owned by Jiangsu Hengrui Pharmaceuticals. The global rights exclude mainland China, Taiwan, Hong Kong and Macau, according to a statement to the Hong Kong stock exchange on Monday. The deal is the latest in a string of transactions between multinational firms and Chinese drug developers, which have bolstered China's share of global licensing deal value to 28 per cent in 2024 from 1 per cent in 2019. Pfizer agreed in May to pay US$1.25 billion to Shenyang-based 3SBio for the exclusive right to develop the Chinese company's drug for treating solid tumours. China's pharmaceutical out-licensing value soared to almost US$66 billion in the first six months of 2025, more than the whole of last year, according to a July 14 report from China Post Securities. For multinational companies, the deals gave them exclusive products to expand their portfolio and pipelines, while the Chinese developers saw them as opportunities to cash in on prior work and fund new projects. The GSK corporate flag next to a Chinese national flag outside its office building in Shanghai on July 12, 2013. Photo: Reuters Hengrui, established in the Jiangsu provincial city of Lianyungang in 1997, would receive a US$500 million upfront payment and charge US$12 billion to GSK upon the achievement of development, regulatory approval and sales milestones. 'The signing of the agreement will help expand the international market for HRS-9821 and multiple innovative medicines in various therapeutic areas, including oncology, respiratory, immunology and inflammation, providing high-quality treatment options for patients worldwide,' Hengrui said in a statement.


South China Morning Post
an hour ago
- South China Morning Post
‘More important than life': cancer-stricken China dancer keeps performing in major shows
A famous dancer in China who was diagnosed with breast cancer and endured dozens of rounds of medical treatment last year still devotes herself to dancing. Advertisement Zhu Jiejing, a 39-year-old principal dancer with the Shanghai Dance Theatre Company, says dancing is more important to her than life itself. Zhu shot to fame with her lead roles in prominent dances at the state media CCTV's Spring Festival Gala Show four times in the past five years. The show is the most watched TV programme in China. She was absent from the stage for almost a year in 2024 after being diagnosed with breast cancer. Zhu Jiejing shot to fame with her regular appearances on the most watched television show in China. Photo: Baidu Zhu surgery on her left breast and endured chemotherapy and radiotherapy, the Xinmin Evening News reported.


South China Morning Post
an hour ago
- South China Morning Post
South Korea pitches ‘Make American Shipbuilding Great Again' plan to avert Trump tariffs
South Korea is pitching the US on a shipbuilding partnership as a key proposal to seal a last-minute agreement to avoid a 25 per cent tariff rate. While details remain unclear, Yonhap News reported that South Korea has proposed a multibillion-dollar project dubbed 'Make American Shipbuilding Great Again' (Masga). South Korea's Industry Ministry declined to comment. 'We confirmed the US side's strong interest in the shipbuilding sector and the two countries agreed to work together to develop mutually acceptable terms that include shipbuilding cooperation,' South Korea's presidential office said in a statement on Saturday. As countries across Asia clinched deals last week, Seoul's negotiators have been racing to stay engaged with their US counterparts as Washington shifted its focus to the European Union and China. The US and EU announced a pact on Sunday that will see the bloc face 15 per cent tariffs on most of its exports to the US, including automobiles. The latest agreement, which follows a Japan deal last week , adds to the pressure on Asia's fourth-largest economy to clinch a deal. South Korea, where negotiations have been slowed by internal political turmoil, is one of the biggest Asian economies to still be without a deal. In addition to China India is another major exporter in the region currently engaged in negotiations.